---
truth_dimension: procedural
authority_level: authoritative
mutation_path: checklist_revision
---

# Current phase checklist - Phase 122 Controlled Early Human-Use Trial Boundary

## Phase name
- [x] Phase 122 - Controlled Early Human-Use Trial Boundary.

## Phase goal
- [x] Define controlled early-human-use trial procedure, participant constraints, role ownership, manual review, evidence capture, stop-condition handling, escalation disposition, and Phase 123 handoff only.
- [x] Preserve Phase 120 constrained early-human-use candidate posture.
- [x] Do not approve Release Candidate status, Production Candidate status, public/general use, production readiness, production deployment, or production human use.

## Working-tree hygiene gate
- [x] Run `git status --short` before edits.
- [x] Classify uncommitted files before edits.
- [x] Remove generated artifact drift before edits if present.
- [x] Keep staged files limited to allowed Phase 122 surfaces.

## Allowed surfaces
- [x] `docs/operations/controlled-early-human-use-trial-boundary-phase-122.md` may be created.
- [x] `checklists/current-phase.md` may be updated.
- [x] `CHANGELOG.md` may be updated.
- [x] No Rust, TypeScript, test, schema, script, workflow, package, lockfile, governance, architecture, roadmap, README, AGENTS, archived changelog, deployment, or release infrastructure changes are required for Phase 122.

## Boundary rules
- [x] Phase 122 is controlled early-human-use trial boundary only.
- [x] Phase 122 does not expand early-human-use authority beyond Phase 120 constraints.
- [x] Phase 122 does not implement Phase 123.
- [x] Phase 122 does not add runtime behavior or new capability.

## Evidence-only checklist
- [x] Count only committed source files, tests, UI behavior tests, validation scripts, governance docs, architecture docs, roadmap docs, operations docs, changelog surfaces, checklists, schemas, and CI/workflow files as evidence.
- [x] Do not count prompt intent, prior chat summaries, uncommitted work, speculative roadmap claims, or future phase descriptions as implemented behavior.
- [x] Do not treat passing validation as release approval or readiness approval.
- [x] Do not treat absence of blockers as approval.

## Phase 120 relationship checklist
- [x] Phase 120 is complete.
- [x] Phase 120 remains Early Human-Use Candidate Gate only.
- [x] Phase 120 permitted `early_human_use_candidate_permitted_with_constraints` only.
- [x] The permitted posture is bounded, non-public, local/trial-only, manually reviewed, and constrained to named internal/trial participants.
- [x] Phase 120 is not Release Candidate approval, Production Candidate approval, public/general use, production readiness, production deployment, or production human use.

## Phase 121 relationship checklist
- [x] Phase 121 is complete.
- [x] Phase 121 remains roadmap expansion and production gap reassessment only.
- [x] Phase 121 mapped Phase 122 as controlled early-human-use trial work only.
- [x] Phase 121 mapped Phase 125 as the next 0/5 checkpoint.
- [x] Phase 121 mapped Phase 130 as Release Candidate Decision Gate only.
- [x] Phase 121 did not approve Release Candidate status, Production Candidate status, public/general use, production readiness, production deployment, or production human use.

## Ladder-Preservation Invariant checklist
- [x] Ladder steps are not interchangeable.
- [x] No implicit promotion from trial success, validation success, operator notes, human feedback, or absence of blockers.
- [x] Absence of blockers is not approval.
- [x] Evidence assembly is not readiness.
- [x] Dry runs are not release.
- [x] Decision gates may approve only their explicitly authorized decision.
- [x] Phase 122 cannot retroactively rewrite earlier gates.
- [x] Human use is not binary.
- [x] Deployment is not release.
- [x] Phase 122 is not the final gate.
- [x] Public/general use is always the final rung.
- [x] No trust inference from provider output, operator notes, participant notes, or feedback.
- [x] No cross-category inference between trial, usability, operator workflow, observability, security, release, and governance evidence.
- [x] No authority activation without explicit roadmap permission.
- [x] Every rung requires its own evidence.
- [x] Roadmap continuation remains required.

## Production-human-use ladder checklist
- [x] Preserve Local operator testing.
- [x] Preserve Controlled human trial.
- [x] Preserve Early human-use candidate.
- [x] Preserve Release candidate.
- [x] Preserve Production candidate.
- [x] Preserve Public/general use.
- [x] Phase 122 operates only within the Early human-use candidate rung.

## Trial participant boundary checklist
- [x] Participants are limited to named internal/trial participants.
- [x] Anonymous users, public users, production users, broad internal distribution, and general availability audiences are outside the boundary.

## Named participant checklist
- [x] Participant records must identify the named internal/trial participant.
- [x] Participant records must identify trial session, local/non-public context, manual-review owner, evidence capture location, and restrictions acknowledged before participation.

## Trial coordinator ownership checklist
- [x] A named Trial coordinator owns the trial boundary, participant list, scheduling, evidence completeness, stop-condition evaluation, manual-review routing, and Phase 123 handoff.
- [x] Missing Trial coordinator yields `trial_blocked` or `trial_deferred`.

## Operator responsibilities checklist
- [x] Operators keep the trial local/non-public.
- [x] Operators use only permitted existing validation/reporting surfaces.
- [x] Operators avoid production and release claims.
- [x] Operators collect session evidence and route exceptions to the Trial coordinator.
- [x] Operators stop on stop conditions.

## Reviewer responsibilities checklist
- [x] Reviewers perform manual review before trial evidence is usable for Phase 123 review.
- [x] Reviewers keep evidence categories separate.
- [x] Reviewers reject readiness language and verify stop-condition handling.

## Security reviewer escalation checklist
- [x] Escalate security issues, abuse paths, provider-output trust concerns, sensitive-data exposure, network exposure, permission drift, filesystem mutation concerns, and action-execution concerns to the Security reviewer.
- [x] Security reviewer escalation never creates readiness approval.

## Release steward escalation checklist
- [x] Escalate release, public-use, deployment, packaging, installer, update-channel, signing, publishing, GitHub release, release tag, public download, Release Candidate, Production Candidate, public-usability, production-readiness, production-deployment, or production-human-use claims to the Release steward.
- [x] Release steward escalation records are non-approval records.

## Manual-review checklist
- [x] Manual review is required for participant admission, session evidence, feedback evidence, stop-condition disposition, escalations, residual-risk carry-forward, and Phase 123 handoff.
- [x] Automated validation output is evidence only.

## Local/non-public trial posture checklist
- [x] The trial remains bounded, non-public, local/trial-only, and constrained to named internal/trial participants.
- [x] No background services, daemon behavior, production deployment behavior, public release behavior, or network expansion are added.

## Evidence capture checklist
- [x] Capture trial status, participant boundary, named participants, Trial coordinator, operators, reviewers, Security reviewer escalations, Release steward escalations, manual-review disposition, local/non-public posture, session evidence, feedback evidence, stop conditions, success/failure criteria, residual risks, and Phase 123 handoff status.

## Session evidence checklist
- [x] Session evidence includes session identifier, date, named participant, Trial coordinator, operator, reviewer, local environment summary, surfaces used, validation commands run, observed outcomes, stop-condition checks, manual-review disposition, and residual-risk notes.

## Feedback evidence checklist
- [x] Feedback evidence preserves participant notes, operator notes, reviewer notes, friction points, confusing UI or workflow states, suspected safety issues, release/public-use language, and suggested follow-ups as untrusted descriptive evidence.

## Stop-condition checklist
- [x] Stop on security issue discovery.
- [x] Stop on public-use, release-readiness, Production Candidate, production-readiness, production-deployment, or production-human-use claims.
- [x] Stop on provider-output trust, action-execution, replay-repair, recovery-promotion, or persistence-authority expansion attempts.
- [x] Stop on deployment automation or release artifact/package/installer/update/signing/publishing/GitHub release/tag/public asset attempts.
- [x] Stop on participant-boundary breach, missing Trial coordinator, missing manual review, missing evidence capture, or unresolved sensitive-data concern.

## Success/failure criteria checklist
- [x] Success requires documented boundary, preserved Phase 120 constraints, preserved Phase 121 relationships, explicit participant/role/manual-review/evidence/stop-condition/handoff requirements, and no later-rung approval or behavior.
- [x] Failure or blocked status applies if authority expands, prohibited behavior is introduced, absence of blockers is treated as approval, prohibited statuses are used, role/manual-review/escalation/evidence requirements are omitted, evidence categories collapse, or Phase 123 is implemented.

## Residual-risk carry-forward checklist
- [x] Residual risks remain descriptive and carry forward to Phase 123 review without promotion.
- [x] Unresolved participant, security, release-boundary, usability, operator-workflow, observability, governance, provider-output, persistence, recovery, replay, action-execution, deployment, or public-use risks remain open until a future authorized phase.

## Evidence-category separation checklist
- [x] Keep trial evidence separate from usability evidence.
- [x] Keep operator workflow evidence separate from observability evidence.
- [x] Keep security evidence separate from release evidence.
- [x] Keep governance, roadmap, changelog, and validation evidence separate.

## Provider-output/human-feedback trust prohibition checklist
- [x] Provider output remains untrusted.
- [x] Human feedback remains untrusted descriptive input.
- [x] No provider trust, provider output promotion, readiness, safety, authority, or approval is inferred from notes or feedback.

## Phase 123 handoff checklist
- [x] Handoff package should include boundary definition, participant list, Trial coordinator record, operator/reviewer records, manual-review dispositions, session evidence, feedback evidence, stop-condition log, escalations, residual-risk list, and explicit non-approval statements.
- [x] Phase 123, if recommended, is early human-use evidence review and operator feedback audit only.
- [x] Phase 122 does not implement Phase 123.

## Phase 125 checkpoint expectation checklist
- [x] Phase 125 remains the next 0/5 checkpoint.
- [x] Phase 125 must reconcile Phase 121-124 outcomes before release-candidate hardening may proceed.

## Phase 130 deferral checklist
- [x] Phase 130 remains Release Candidate Decision Gate only.
- [x] Phase 122 does not approve Release Candidate status or release-candidate readiness.

## Release artifact prohibition checklist
- [x] No release artifacts are created.
- [x] No packages are created.

## Deployment automation prohibition checklist
- [x] No deployment automation is added.
- [x] No background services or daemon behavior are added.

## Installer/update-channel prohibition checklist
- [x] No installer behavior is added.
- [x] No update-channel behavior is added.

## Signing/publishing prohibition checklist
- [x] No signing behavior is added.
- [x] No publishing behavior is added.

## GitHub release/tag/public asset prohibition checklist
- [x] No GitHub release is created.
- [x] No release tag is created.
- [x] No public download or public asset is created.

## Public-release prohibition checklist
- [x] No public release behavior is added.
- [x] Public release remains prohibited for Phase 122.

## Production-deployment prohibition checklist
- [x] No production deployment behavior is added.
- [x] Production deployment remains prohibited for Phase 122.

## Public/general-use approval prohibition checklist
- [x] Public/general use is not approved.
- [x] Public usability is not approved.

## Production-human-use approval prohibition checklist
- [x] Production human use is not approved.

## Production Candidate approval prohibition checklist
- [x] Production Candidate status is not approved.

## Release-candidate approval prohibition checklist
- [x] Release Candidate status is not approved.
- [x] Release-candidate readiness is not approved.

## Provider trust/output promotion prohibition checklist
- [x] Provider trust is not added.
- [x] Provider output is not promoted.

## Replay-repair prohibition checklist
- [x] Replay repair is not added.

## Recovery-promotion prohibition checklist
- [x] Recovery promotion is not added.

## Action-execution prohibition checklist
- [x] Action execution is not added.

## Readiness prohibition checklist
- [x] Readiness approval is not added.
- [x] Production readiness, release readiness, public readiness, and human-use readiness are not approved.

## Production Candidate status checklist
- [x] Production Candidate status remains not approved.
- [x] Phase 122 evidence cannot satisfy Production Candidate requirements by inheritance.

## Release-candidate/public-use status checklist
- [x] Release-candidate readiness remains not approved.
- [x] Public/general use remains not approved and remains the final rung.

## Roadmap/changelog truth checklist
- [x] Roadmap remains planned truth.
- [x] CHANGELOG surfaces remain historical truth.
- [x] Phase 122 operations report remains advisory orientation evidence.

## Validation checklist
- [ ] Run `CARGO_TARGET_DIR=/tmp/ajentic-phase-122-target ./scripts/check.sh`.
- [ ] Run `git diff --check`.
- [ ] Run `git status --short`.
- [ ] Run Phase 122 trial boundary scan.
- [ ] Run ladder invariant scan.
- [ ] Run phase relationship scan.
- [ ] Run participant/evidence scan.
- [ ] Run no-deployment/release authority scan.
- [ ] Run no-authority scan.
- [ ] Run readiness scan.
- [ ] Run source guard.

## Findings table
| Finding | Status | Evidence |
| --- | --- | --- |
| Controlled early-human-use trial boundary defined | `trial_boundary_defined` | Phase 122 operations report |
| Release Candidate approval | `not_applicable` | Explicitly prohibited |
| Production Candidate approval | `not_applicable` | Explicitly prohibited |
| Public/general use approval | `not_applicable` | Explicitly prohibited |
| Production human-use approval | `not_applicable` | Explicitly prohibited |

## Trial evidence table
| Evidence category | Required Phase 122 handling | Status |
| --- | --- | --- |
| Participant boundary | Named internal/trial participants only | `trial_boundary_defined` |
| Trial coordinator ownership | Named Trial coordinator required | `trial_boundary_defined` |
| Manual review | Required before Phase 123 handoff | `trial_requires_manual_review` |
| Session evidence | Capture required per trial session | `trial_boundary_defined` |
| Feedback evidence | Capture as untrusted descriptive evidence | `trial_boundary_defined` |
| Stop conditions | Active and preserved | `trial_boundary_defined` |

## Residual risks table
| Risk | Carry-forward handling | Status |
| --- | --- | --- |
| Security issue during trial | Security reviewer escalation | `trial_requires_manual_review` |
| Release/public-use claim during trial | Release steward escalation | `trial_requires_manual_review` |
| Missing named participant | Stop condition | `trial_stop_condition_active` |
| Missing Trial coordinator | Block or defer trial | `trial_blocked` |
| Missing manual review | Stop condition | `trial_stop_condition_active` |
| Evidence category collapse | Reject as non-compliant | `trial_blocked` |

## Deferred items table
| Deferred item | Phase 122 status |
| --- | --- |
| Phase 123 implementation | Deferred |
| Release artifacts/packages | Prohibited |
| Installer/update channels | Prohibited |
| Signing/publishing | Prohibited |
| GitHub release/tag/public assets | Prohibited |
| Public release | Prohibited |
| Production deployment | Prohibited |
| Provider trust/output promotion | Prohibited |
| Persistence authority expansion | Prohibited |
| Replay repair | Prohibited |
| Recovery promotion | Prohibited |
| Action execution | Prohibited |
| Release Candidate approval | Prohibited |
| Production Candidate approval | Prohibited |
| Public/general-use approval | Prohibited |
| Production-human-use approval | Prohibited |

## Validation log table
| Command | Result | Notes |
| --- | --- | --- |
| `CARGO_TARGET_DIR=/tmp/ajentic-phase-122-target ./scripts/check.sh` | Pending | Run after final edits |
| `git diff --check` | Pending | Run after final edits |
| `git status --short` | Pending | Run after final edits |
| Phase 122 trial boundary scan | Pending | Run after final edits |
| Ladder invariant scan | Pending | Run after final edits |
| Phase relationship scan | Pending | Run after final edits |
| Participant/evidence scan | Pending | Run after final edits |
| No-deployment/release authority scan | Pending | Run after final edits |
| No-authority scan | Pending | Run after final edits |
| Readiness scan | Pending | Run after final edits |
| Source guard | Pending | Run after final edits |

## Zero-drift checklist
- [x] No generated artifacts are intentionally retained.
- [x] No source, test, schema, script, workflow, package, lockfile, governance, architecture, roadmap, README, AGENTS, archived changelog, deployment, release, provider execution, persistence, replay repair, recovery promotion, action execution, installer, update, signing, publishing, public release, or production deployment files are modified for Phase 122.
- [x] CHANGELOG entry matches the actual Phase 122 diff intent.
- [x] No readiness approval claims are introduced.
